Ordinary Adjustment | Solactive Eli Lilly Value Chain Index | Effective Date 8th May 2025
Solactive Eli Lilly Value Chain Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th May 2025:
SAMSUNG BIOLOGICS CO LTD |
ELI LILLY & CO |
LONZA GROUP AG |
THERMO FISHER SCIENTIFIC INC |
CHUGAI PHARMACEUTICAL CO LTD ORD |
ICON PLC |
UNITED THERAPEUTICS CORP |
SHIONOGI & CO LTD ORD |
INCYTE CORP |
HALOZYME THERAPEUTICS INC |
TECAN GROUP AG-REG |
BACHEM HOLDING AG-REG B |
AMPHASTAR PHARMACEUTICALS INC |
VEEVA SYSTEMS INC |
SCHRODINGER INC |